GHK vs GHK-Cu: What Changes When Copper Is Added?

GHK and GHK-Cu are the same tripeptide -- glycyl-L-histidyl-L-lysine -- separated by one copper ion. That ion is not decorative. It changes the peptide's 3D shape, enables copper-dependent enzyme activation, and expands its gene expression footprint from a narrow repair signal to a compound that modulates over 4,000 human genes.

The short answer: GHK signals cells to start repair. GHK-Cu signals cells to start repair AND actively participates in the repair through copper-dependent pathways. For nearly every practical application -- skincare, wound healing, injectable protocols -- GHK-Cu is the form you want.

If you already know both peptides, skip to the side-by-side table or which one to choose.

Table of Contents

• The Two Forms at a Glance
• The Structural Difference: One Ion, Major Consequences
• Bioavailability and Stability
• Mechanism of Action: What Copper Adds
• Gene Expression: The 4,000-Gene Question
• Research Evidence
• GHK vs GHK-Cu: Side-by-Side Comparison
• Practical Applications
• Which Should You Choose?
• Frequently Asked Questions
• References

The Two Forms at a Glance

GHK is a tripeptide first identified in human plasma in 1973 by Dr. Loren Pickart. It circulates in blood, saliva, and urine as a fragment of extracellular matrix (ECM) proteins -- the structural scaffolding that holds tissues together. GHK functions as a matrikine: a small peptide signal that tells nearby cells tissue has been damaged and needs repair. Plasma levels decline roughly 60% between age 20 and 60 (Pickart et al., 2012). Full profile: GHK on PeptideWiki.

GHK-Cu is the same backbone with a copper(II) ion chelated (chemically bound in a stable coordination complex) between the histidine and glycine residues. Also called Copper Tripeptide-1, it is the form used in virtually all published research and every commercial copper peptide product. The copper enables enzymatic pathways the free peptide cannot access. Full profile: GHK-Cu on PeptideWiki.

One fact bridges these forms: free GHK has an extremely high affinity for copper(II) ions. In any biological fluid where copper is present, GHK rapidly binds it and converts to GHK-Cu. Free GHK is a transient intermediate -- it does not stay "free" for long in the body (Pickart et al., 2015). This rapid conversion is why the research community often uses the names interchangeably, and why nearly all functional data describes the copper-bound form.

The Structural Difference

GHK has a molecular weight of approximately 340 Da (daltons -- the standard unit for molecular mass). It has an open coordination site formed by nitrogen atoms of the histidine imidazole ring and the terminal amine group -- a copper-shaped parking space that exists whether copper is present or not (Pickart & Margolina, 2018).

GHK-Cu weighs approximately 403 Da (340 + 63 for the copper ion). The copper sits in a square-planar coordination geometry, bound by four nitrogen/oxygen donor atoms. This creates a rigid, compact structure substantially more stable than the free peptide (Hureau et al., 2011).

Why does 63 Da matter?

1. The copper changes the peptide's 3D shape. Copper binding locks the tripeptide into a specific conformation. Cell surface receptors recognize shapes, not just amino acid sequences. The copper-bound conformation fits binding pockets the floppy, free peptide does not.

2. The copper enables redox chemistry. Copper(II) can accept and donate electrons, making GHK-Cu a participant in oxidation-reduction reactions. This is directly relevant to its interaction with copper-dependent enzymes like superoxide dismutase (SOD) and lysyl oxidase -- the enzyme essential for collagen cross-linking (Pickart et al., 2012).

3. The copper enables metalloproteinase regulation. Matrix metalloproteinases (MMPs) -- enzymes that break down extracellular matrix -- are zinc- and calcium-dependent. GHK-Cu modulates MMP activity through copper-mediated interactions. Free GHK lacks this capability (Pickart et al., 2015).

Bioavailability and Stability

Stability in solution. Free GHK degrades faster without copper to lock its structure. The open backbone is more susceptible to protease degradation (proteases are enzymes that cut peptide bonds). GHK-Cu's chelation protects the backbone, extends shelf life, and gives it a longer functional window in tissue. This is the primary reason all commercial products use GHK-Cu (Pickart et al., 2015).

Topical penetration. GHK-Cu's 403 Da molecular weight falls below the 500 Da threshold generally considered the upper limit for skin penetration. Studies confirm measurable skin penetration with topical GHK-Cu, which is why it became a mainstream cosmetic ingredient. Free GHK's topical penetration has not been studied extensively because it is not commercially used in topical products (Pickart et al., 2012).

Injectable bioavailability. When injected subcutaneously, free GHK binds plasma copper and converts to GHK-Cu in vivo. The practical difference for injection is smaller than for topical use -- but starting with the pre-formed complex avoids an unnecessary conversion step and ensures consistent delivery.

Mechanism of Action: What Copper Adds

What GHK does without copper

Free GHK retains biological activity as a matrikine signal:

• Chemotaxis. GHK acts as a chemical "come here" signal for fibroblasts, immune cells, and mast cells. This relies on the peptide sequence being recognized by cell surface receptors, not on copper (Pickart, 2008).
• Glycosaminoglycan (GAG) synthesis. GAGs are hydrating molecules in the extracellular matrix (hyaluronic acid is the most familiar). GHK stimulates their production independently of copper, though less potently than GHK-Cu (Maquart et al., 1999).
• Copper delivery. In copper-rich environments, GHK acts as a shuttle -- binding copper and delivering it to cells for enzymatic reactions. This carrier function may be its most important in vivo role as a free peptide (Pickart & Margolina, 2018).

What copper enables

When copper is bound, GHK-Cu gains capabilities the free peptide lacks:

• Collagen synthesis. GHK-Cu upregulates collagen types I, III, and IV, along with elastin and decorin. The copper ion activates lysyl oxidase, the enzyme that cross-links collagen fibers into functional networks. A 12-week facial study showed GHK-Cu cream increased skin thickness by 29% versus control (Maquart et al., 1999; Siméon et al., 1999; reviewed in Pickart et al., 2012).
• Antioxidant enzyme activation. GHK-Cu upregulates superoxide dismutase (SOD) and ferritin, and activates the Nrf2 pathway (a master regulator of cellular antioxidant response). These effects depend on the copper ion's redox activity (Pickart et al., 2012).
• MMP/TIMP regulation. GHK-Cu modulates the balance between matrix metalloproteinases (tissue breakdown) and their inhibitors, TIMPs (tissue protection). This balanced regulation enables controlled remodeling rather than unchecked degradation or excessive scarring (Siméon et al., 1999).
• Anti-inflammatory signaling. GHK-Cu suppresses pro-inflammatory cytokines including IL-6, TNF-alpha, and TGF-beta1 through NF-kB pathway modulation. It also reduces TGF-beta signaling associated with fibrosis (pathological scarring) -- this dual anti-inflammatory and anti-fibrotic action is unusual and clinically relevant (Pickart et al., 2015).
• Nerve growth factor stimulation. GHK-Cu increases nerve growth factor (NGF) production, relevant to nerve regeneration after injury. This has not been demonstrated with free GHK (Pickart, 2008).

Gene Expression: The 4,000-Gene Question

A 2014 Connectivity Map analysis found that GHK-Cu modulates the expression of 4,048 human genes -- approximately 6% of the human genome (Pickart et al., 2014).

The 4,048 genes cluster into patterns associated with:

• Tissue remodeling -- upregulation of collagen, elastin, and ECM structural proteins
• Antioxidant defense -- upregulation of SOD, glutathione pathways, and DNA repair genes
• Anti-inflammatory response -- suppression of NF-kB targets and pro-inflammatory cytokine genes
• Anti-cancer signaling -- suppression of genes associated with metastasis (notably TGF-beta pathways)
• Nerve regeneration -- upregulation of genes involved in nerve outgrowth and repair

This analysis used GHK-Cu, not free GHK. No equivalent analysis exists for the free peptide. The biochemistry predicts free GHK would show a substantially smaller footprint because copper-dependent pathways would not activate (Pickart et al., 2014).

Research Evidence

Most published studies use GHK-Cu as the test compound, even when the paper's title says "GHK." The research base for the free peptide is thin by comparison.

Wound healing. In animal models, GHK-Cu accelerated wound contraction, increased collagen deposition, and stimulated angiogenesis (new blood vessel formation). Treated wounds showed more organized collagen architecture and less scar tissue (Siméon et al., 1999). Free GHK contributes by attracting fibroblasts and immune cells to the wound site -- its original matrikine role (Pickart, 1973).

Skin rejuvenation. Human clinical trials with topical GHK-Cu showed improved firmness, reduced fine lines, increased skin thickness and density, and improved clarity (reviewed in Pickart et al., 2012). No equivalent clinical data exists for free GHK in skincare.

Lung tissue repair. Gene expression analysis suggests GHK-Cu could reverse the gene signature of COPD (chronic obstructive pulmonary disease) toward a healthier pattern. This is preclinical and remains an active research area (Campbell et al., 2012).

Hair growth support. GHK-Cu supports scalp health through collagen production, reduced inflammation, and enhanced dermal blood flow. Some in vitro evidence suggests it may increase hair follicle size (Pickart et al., 2012). For targeted hair growth, AHK-Cu is the more specific copper peptide.

Copper transport. Free GHK's distinct role. As a copper carrier, GHK delivers copper ions to tissues with high enzymatic demand -- relevant in copper-deficient states. Here, GHK is the delivery vehicle rather than the active compound (Pickart & Margolina, 2018).

GHK vs GHK-Cu: Side-by-Side Comparison

Feature	GHK (Free Peptide)	GHK-Cu (Copper Complex)
Structure	Gly-His-Lys tripeptide	Gly-His-Lys + Cu2+ ion
Molecular weight	~340 Da	~403 Da
Natural occurrence	Yes (plasma, saliva, urine)	Yes (forms when GHK binds Cu2+)
Stability in solution	Low -- degrades faster	Higher -- copper chelation protects backbone
Collagen stimulation	Weak without copper	Strong (collagen I, III, IV, elastin, decorin)
Gene expression scope	Not characterized at scale	4,048 genes (~6% of human genome)
Antioxidant activity	Minimal	SOD upregulation, Nrf2 activation, ferritin
MMP/TIMP regulation	Not demonstrated	Balanced modulation of tissue remodeling
Anti-inflammatory	Limited	NF-kB suppression, cytokine modulation
Chemotactic signaling	Yes -- attracts fibroblasts, immune cells	Yes -- retained from GHK backbone
Topical use	Not commercially available	Widely used (serums, creams at 1-2%)
Injectable use	Converts to GHK-Cu in vivo	Standard (1-2 mg/day subcutaneous)
Commercial products	None	Hundreds of skincare formulations
Research volume	Moderate (studied as precursor)	Extensive (hundreds of publications)
FDA status (injectable)	Not specifically regulated	Category 2 (compounding restricted)
Primary role	Signaling fragment, copper carrier	Active therapeutic/cosmetic compound

Practical Applications

Skin and Anti-Aging

GHK-Cu is the only form with published skin data and the only form in commercial products. Applied topically at 1-2% concentration, it delivers copper directly to dermal fibroblasts for collagen synthesis, fine line reduction, and skin density improvement.

Wound Healing

GHK-Cu. The copper ion activates lysyl oxidase (collagen cross-linking) and modulates MMPs/TIMPs (balanced tissue remodeling). Apply topically to closed wounds -- wait until the initial open/inflammatory phase has resolved before introducing copper peptide products.

Injectable Protocols

GHK-Cu is the standard. Typical research protocols use 1-2 mg daily via subcutaneous injection in 4-8 week cycles.

Regulatory note: Injectable GHK-Cu is currently FDA Category 2, meaning compounding pharmacies cannot produce it. Topical GHK-Cu is unaffected. See the GHK-Cu dosage guide for full protocol details, or use the peptide dosage calculator for reconstitution math.

Copper Delivery Research

The one context where free GHK has a distinct role. As a copper carrier, it delivers copper ions to tissues with high enzymatic demand. This is a biochemistry application, not a consumer use case. See the GHK dosage guide for details.

Which Should You Choose?

GHK-Cu. For nearly every use case.

• Skincare? GHK-Cu. Every published skin study, every commercial product.
• Wound healing? GHK-Cu. Collagen cross-linking and MMP/TIMP regulation are copper-dependent.
• Gene expression modulation? GHK-Cu. The 4,048-gene profile was measured with this form.
• Topical product? GHK-Cu. No free GHK topical products exist.
• Injectable protocol? GHK-Cu. Delivers the active complex directly.

The only exception: copper delivery research -- studying how GHK transports copper to tissues. This is basic science, not a consumer application.

GHK-Cu is more stable, more biologically active, commercially available, and backed by the overwhelming majority of published research. Unless you are conducting copper transport experiments, it is the form you want.

For full profiles: GHK | GHK-Cu | GHK-Cu vs AHK-Cu

Frequently Asked Questions

Is GHK-Cu just GHK with copper added?

Structurally, yes -- same tripeptide plus a copper(II) ion. Functionally, the copper changes the peptide's 3D conformation, enables redox chemistry, activates copper-dependent enzymes, and expands its gene expression footprint from narrow signaling to broad tissue remodeling. Same backbone, fundamentally different capabilities.

Does free GHK have any benefits on its own?

Yes. It attracts fibroblasts, macrophages, and mast cells to injury sites (chemotaxis) and stimulates glycosaminoglycan synthesis. It also serves as a copper transport peptide. However, its highest-impact functions -- collagen synthesis, antioxidant enzyme activation, MMP regulation, and the 4,048-gene expression profile -- all require the copper ion.

Why do most products use GHK-Cu instead of GHK?

Stability, efficacy, and evidence. GHK-Cu is more stable in formulations, more biologically active, and backed by virtually all published clinical data.

Can I use GHK-Cu with vitamin C or AHAs?

Use them at different times. High-concentration L-ascorbic acid, glycolic acid, and other strong acids can disrupt the copper-peptide bond. Apply copper peptides and acid-based products at opposite times of day.

Is GHK-Cu the same as "copper peptide" in skincare?

Usually. The INCI name "Copper Tripeptide-1" refers to GHK-Cu. Other copper peptides exist -- like AHK-Cu (Copper Tripeptide-3) -- but GHK-Cu is the most common by a wide margin.

How is GHK-Cu different from AHK-Cu?

GHK-Cu is a broad tissue remodeler. AHK-Cu is engineered specifically for hair growth, targeting dermal papilla cells. The structural difference is one amino acid: alanine replaces glycine. Full comparison: GHK-Cu vs AHK-Cu.

Is injectable GHK-Cu still available?

Injectable GHK-Cu is FDA Category 2, restricting compounding pharmacy production. Topical GHK-Cu is unaffected and widely available over the counter. See the GHK-Cu dosage guide for current status.

References

1. Pickart L. The use of human plasma growth factors in cosmetics. Nature. 1973. PubMed

2. Maquart FX, Bellon G, Chaqour B, et al. In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds. J Clin Invest. 1993;92(5):2368-2376. PubMed

3. Siméon A, Wegrowski Y, Bontemps Y, Maquart FX. Expression of glycosaminoglycans and small proteoglycans in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu(2+). J Invest Dermatol. 2000;115(6):962-968. PubMed

4. Hureau C, Eury H, Sapber R, et al. X-ray and solution structures of Cu(II)GHK and Cu(II)DAHK complexes: influence on their redox properties. Chemistry. 2011;17(36):10151-10160. PubMed

5. Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015;2015:648108. PubMed

6. Pickart L, Vasquez-Soltero JM, Margolina A. GHK-Cu may prevent oxidative stress in skin by regulating copper and modifying expression of numerous antioxidant genes. Cosmetics. 2015;2(3):236-247. PubMed

7. Pickart L, Vasquez-Soltero JM, Margolina A. The effect of the human peptide GHK on gene expression relevant to nervous system function and cognitive decline. Brain Sci. 2017;7(2):20. PubMed

8. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987. PubMed

9. Campbell JD, McDonough JE, Zeskind JE, et al. A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK. Genome Med. 2012;4(8):67. PubMed

10. Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-988. PubMed

---

PeptideWiki provides educational information about research peptides. This content is not medical advice. Always consult with a qualified healthcare provider before beginning any peptide protocol. See our full disclaimer for details.